QTRX.NASDAQQuanterix CORP

Form 4: Quanterix Director William P. Donnelly Reports Stock and Option Transactions

Sentiment:

SEC Form 4


Director William P. Donnelly of Quanterix Corp. reports acquiring shares and stock options, including restricted stock units, on January 2, 2025.

Summary

  • William P. Donnelly, a director at Quanterix Corp, reported several transactions involving the company's stock on January 2, 2025.
  • These transactions include the acquisition of 7,435 shares of common stock as restricted stock units, which vest on December 31, 2025.
  • Additionally, 1,282 shares were acquired at a price of $10.76 per share, representing stock granted in lieu of cash fees for board service.
  • Donnelly also acquired 15,821 non-qualified stock options with an exercise price of $10.76, exercisable from December 31, 2025, and expiring on January 2, 2035.
  • Following these transactions, Donnelly's total holdings include 43,300 shares of common stock and 15,821 stock options.

Sentiment

Score: 7

Explanation: The document reflects standard insider transactions, which are generally positive as they align director interests with shareholders. The stock and option grants are a positive sign of confidence in the company's future.

Positives

  • The acquisition of restricted stock units and stock options by a director signals confidence in the company's future performance.
  • The stock grant in lieu of cash fees indicates a commitment to aligning director interests with shareholder value.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

  • Stock option grants and restricted stock units are common forms of compensation for directors in publicly traded companies, particularly in the technology and biotech sectors.
  • The vesting schedule of the restricted stock units, vesting 100% after one year, is a fairly standard practice.
  • The exercise price of the stock options being equal to the market price on the grant date is also a common practice.

Stakeholder Impact

  • The transactions may have a minor positive impact on shareholder sentiment, as they indicate director confidence in the company.
  • The stock grants in lieu of cash fees may be viewed positively by shareholders as it reduces cash outflow.

Key Dates

DateDescription
01/02/2025Date of stock and option transactions.
12/31/2025Vesting date for restricted stock units and exercisable date for stock options.
01/02/2035Expiration date for stock options.
01/06/2025Date of signature of the report.

Keywords

Quanterix, Director, Stock Options, Restricted Stock Units, Insider Trading, Share Acquisition, Board Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.